284 related articles for article (PubMed ID: 6978885)
1. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.
Kuhl DE; Metter EJ; Riege WH; Phelps ME
J Cereb Blood Flow Metab; 1982; 2(2):163-71. PubMed ID: 6978885
[TBL] [Abstract][Full Text] [Related]
2. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
3. The effect of normal aging on patterns of local cerebral glucose utilization.
Kuhl DE; Metter EJ; Riege WH; Hawkins RA
Ann Neurol; 1984; 15 Suppl():S133-7. PubMed ID: 6611114
[TBL] [Abstract][Full Text] [Related]
4. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
[TBL] [Abstract][Full Text] [Related]
7. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
Horwitz B; Duara R; Rapoport SI
Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930
[TBL] [Abstract][Full Text] [Related]
8. Imaging local brain function with emission computed tomography.
Kuhl DE
Radiology; 1984 Mar; 150(3):625-31. PubMed ID: 6607481
[TBL] [Abstract][Full Text] [Related]
9. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
[TBL] [Abstract][Full Text] [Related]
10. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
11. Cerebral glucose utilization during sleep-wake cycle in man determined by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose method.
Maquet P; Dive D; Salmon E; Sadzot B; Franco G; Poirrier R; von Frenckell R; Franck G
Brain Res; 1990 Apr; 513(1):136-43. PubMed ID: 2350676
[TBL] [Abstract][Full Text] [Related]
12. 18f-fluorodeoxyglucose method for measuring local cerebral glucose metabolism in man: technique and results.
Reivich M; Alavi A; Greenberg J; Farkas T; Wolf A
Prog Nucl Med; 1981; 7():138-48. PubMed ID: 7323304
[No Abstract] [Full Text] [Related]
13. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
14. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age.
Loessner A; Alavi A; Lewandrowski KU; Mozley D; Souder E; Gur RE
J Nucl Med; 1995 Jul; 36(7):1141-9. PubMed ID: 7790936
[TBL] [Abstract][Full Text] [Related]
15. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.
Reivich M; Alavi A; Wolf A; Fowler J; Russell J; Arnett C; MacGregor RR; Shiue CY; Atkins H; Anand A
J Cereb Blood Flow Metab; 1985 Jun; 5(2):179-92. PubMed ID: 3988820
[TBL] [Abstract][Full Text] [Related]
16. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.
Roelcke U; Kappos L; Lechner-Scott J; Brunnschweiler H; Huber S; Ammann W; Plohmann A; Dellas S; Maguire RP; Missimer J; Radü EW; Steck A; Leenders KL
Neurology; 1997 Jun; 48(6):1566-71. PubMed ID: 9191767
[TBL] [Abstract][Full Text] [Related]
17. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.
Fulham MJ; Brunetti A; Aloj L; Raman R; Dwyer AJ; Di Chiro G
J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography study of human brain functional development.
Chugani HT; Phelps ME; Mazziotta JC
Ann Neurol; 1987 Oct; 22(4):487-97. PubMed ID: 3501693
[TBL] [Abstract][Full Text] [Related]
19. Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming.
Heiss WD; Pawlik G; Herholz K; Wagner R; Wienhard K
Brain Res; 1985 Feb; 327(1-2):362-6. PubMed ID: 3872693
[TBL] [Abstract][Full Text] [Related]
20. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
